TWD 14.35
(7.49%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.35 Billion TWD | -0.6% |
2022 | 2.36 Billion TWD | -4.27% |
2021 | 2.47 Billion TWD | 36.5% |
2020 | 1.8 Billion TWD | -3.84% |
2019 | 1.88 Billion TWD | -9.01% |
2018 | 2.06 Billion TWD | -5.65% |
2017 | 2.19 Billion TWD | -9.6% |
2016 | 2.42 Billion TWD | 3.64% |
2015 | 2.33 Billion TWD | -6.0% |
2014 | 2.48 Billion TWD | -11.85% |
2013 | 2.82 Billion TWD | -2.06% |
2012 | 2.88 Billion TWD | 74.7% |
2011 | 1.65 Billion TWD | -13.45% |
2010 | 1.9 Billion TWD | -9.79% |
2009 | 2.11 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 2.37 Billion TWD | 1.0% |
2024 Q2 | 2.34 Billion TWD | -1.25% |
2023 Q3 | 2.34 Billion TWD | -1.71% |
2023 Q4 | 2.35 Billion TWD | 0.2% |
2023 FY | 2.35 Billion TWD | -0.6% |
2023 Q1 | 2.34 Billion TWD | -0.89% |
2023 Q2 | 2.38 Billion TWD | 1.83% |
2022 Q3 | 2.36 Billion TWD | 0.22% |
2022 Q2 | 2.36 Billion TWD | -2.57% |
2022 FY | 2.36 Billion TWD | -4.27% |
2022 Q1 | 2.42 Billion TWD | -1.81% |
2022 Q4 | 2.36 Billion TWD | -0.16% |
2021 Q1 | 2.52 Billion TWD | 39.34% |
2021 Q2 | 2.52 Billion TWD | 0.06% |
2021 FY | 2.47 Billion TWD | 36.5% |
2021 Q3 | 2.5 Billion TWD | -0.68% |
2021 Q4 | 2.47 Billion TWD | -1.43% |
2020 FY | 1.8 Billion TWD | -3.84% |
2020 Q3 | 1.83 Billion TWD | -0.15% |
2020 Q1 | 1.77 Billion TWD | -5.89% |
2020 Q2 | 1.83 Billion TWD | 3.84% |
2020 Q4 | 1.8 Billion TWD | -1.46% |
2019 Q1 | 2.03 Billion TWD | -1.6% |
2019 Q3 | 1.96 Billion TWD | -1.21% |
2019 Q4 | 1.88 Billion TWD | -3.99% |
2019 FY | 1.88 Billion TWD | -9.01% |
2019 Q2 | 1.98 Billion TWD | -2.51% |
2018 Q2 | 2.18 Billion TWD | -1.21% |
2018 Q3 | 2.15 Billion TWD | -1.45% |
2018 Q4 | 2.06 Billion TWD | -3.95% |
2018 Q1 | 2.21 Billion TWD | 0.89% |
2018 FY | 2.06 Billion TWD | -5.65% |
2017 Q1 | 2.36 Billion TWD | -2.55% |
2017 FY | 2.19 Billion TWD | -9.6% |
2017 Q4 | 2.19 Billion TWD | -3.8% |
2017 Q3 | 2.27 Billion TWD | -2.13% |
2017 Q2 | 2.32 Billion TWD | -1.46% |
2016 Q2 | 2.52 Billion TWD | 10.43% |
2016 Q1 | 2.28 Billion TWD | -2.44% |
2016 FY | 2.42 Billion TWD | 3.64% |
2016 Q3 | 2.47 Billion TWD | -1.85% |
2016 Q4 | 2.42 Billion TWD | -1.99% |
2015 Q2 | 2.44 Billion TWD | -4.29% |
2015 FY | 2.33 Billion TWD | -6.0% |
2015 Q4 | 2.33 Billion TWD | -1.94% |
2015 Q3 | 2.38 Billion TWD | -2.32% |
2015 Q1 | 2.55 Billion TWD | 2.54% |
2014 Q2 | 2.69 Billion TWD | -4.12% |
2014 Q1 | 2.81 Billion TWD | -0.48% |
2014 Q3 | 2.57 Billion TWD | -4.33% |
2014 Q4 | 2.48 Billion TWD | -3.45% |
2014 FY | 2.48 Billion TWD | -11.85% |
2013 Q1 | 2.81 Billion TWD | -2.5% |
2013 Q3 | 2.74 Billion TWD | -2.28% |
2013 Q2 | 2.8 Billion TWD | -0.19% |
2013 FY | 2.82 Billion TWD | -2.06% |
2013 Q4 | 2.82 Billion TWD | 3.0% |
2012 Q2 | 1.63 Billion TWD | -4.25% |
2012 FY | 2.88 Billion TWD | 74.7% |
2012 Q1 | 1.7 Billion TWD | 3.23% |
2012 Q4 | 2.88 Billion TWD | 68.47% |
2012 Q3 | 1.71 Billion TWD | 4.9% |
2011 Q2 | 1.79 Billion TWD | -3.37% |
2011 Q1 | 1.85 Billion TWD | -2.75% |
2011 Q3 | 1.7 Billion TWD | -4.71% |
2011 Q4 | 1.65 Billion TWD | -3.35% |
2011 FY | 1.65 Billion TWD | -13.45% |
2010 FY | 1.9 Billion TWD | -9.79% |
2010 Q4 | 1.9 Billion TWD | 0.0% |
2009 FY | 2.11 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Grape King Bio Ltd | 15.51 Billion TWD | 84.847% |
Standard Chem & Pharm CO., LTD. | 11.18 Billion TWD | 78.992% |
Maywufa Company Ltd. | 2.83 Billion TWD | 17.004% |
ScinoPharm Taiwan, Ltd. | 11.72 Billion TWD | 79.947% |
Lotus Pharmaceutical Co., Ltd. | 32.99 Billion TWD | 92.875% |
LIWANLI Innovation Co., Ltd. | 834.17 Million TWD | -181.777% |
YungShin Global Holding Corporation | 11.51 Billion TWD | 79.583% |
SCI Pharmtech, Inc. | 6.69 Billion TWD | 64.869% |
Formosa Laboratories, Inc. | 13.63 Billion TWD | 82.763% |
PharmaEssentia Corporation | 27.26 Billion TWD | 91.38% |
Bora Pharmaceuticals Co., LTD. | 25.05 Billion TWD | 90.617% |